ATAIBECKLEY INC (9VC.DE) Stock Price & Overview
FRA:9VC • NL0015000DX5
Current stock price
The current stock price of 9VC.DE is 3.426 EUR. Today 9VC.DE is down by -1.21%. In the past month the price increased by 6.93%. In the past year, price increased by 163.44%.
9VC.DE Key Statistics
- Market Cap
- 1.244B
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.70
- Dividend Yield
- N/A
9VC.DE Stock Performance
9VC.DE Stock Chart
9VC.DE Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to 9VC.DE. When comparing the yearly performance of all stocks, 9VC.DE is one of the better performing stocks in the market, outperforming 96.95% of all stocks.
9VC.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to 9VC.DE. 9VC.DE has a great financial health rating, but its profitability evaluates not so good.
9VC.DE Earnings
On November 12, 2025 9VC.DE reported an EPS of -0.28 and a revenue of 749.00K. The company missed EPS expectations (-131.54% surprise) and beat revenue expectations (1221.66% surprise).
9VC.DE Forecast & Estimates
18 analysts have analysed 9VC.DE and the average price target is 10.49 EUR. This implies a price increase of 206.11% is expected in the next year compared to the current price of 3.426.
For the next year, analysts expect an EPS growth of 30.67% and a revenue growth 468.25% for 9VC.DE
9VC.DE Groups
Sector & Classification
9VC.DE Financial Highlights
Over the last trailing twelve months 9VC.DE reported a non-GAAP Earnings per Share(EPS) of -0.7.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -62.24% | ||
| ROE | -93.44% | ||
| Debt/Equity | 0 |
9VC.DE Ownership
9VC.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1SAN | SANOFI | 9.77 | 100.393B | ||
| SAN | SANOFI | 9.74 | 100.102B | ||
| SNW | SANOFI | 9.73 | 100.041B | ||
| UCB | UCB SA | 25.72 | 51.448B | ||
| UNC | UCB SA | 25.39 | 50.806B | ||
| MRK | MERCK KGAA | 13.28 | 47.739B | ||
| 1MRK | MERCK KGAA | 13.21 | 47.478B | ||
| 1BAYN | BAYER AG-REG | 8.59 | 39.493B | ||
| BAYN | BAYER AG-REG | 8.48 | 38.997B | ||
| IPN | IPSEN | 13.73 | 14.038B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 17.45 | 10.457B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 9.77B | ||
| VIRP | VIRBAC SA | 16.3 | 2.945B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 9VC.DE
Company Profile
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. The company is headquartered in Amstelveen, Noord-Holland and currently employs 54 full-time employees. The company went IPO on 2021-06-18. The firm focused on developing treatments for mental health disorders. The firm's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.
Company Info
IPO: 2021-06-18
ATAIBECKLEY INC
Prof. J.H.Bavincklaan 7
Amstelveen NOORD-HOLLAND NL
Employees: 54
Phone: 31207932536
ATAIBECKLEY INC / 9VC.DE FAQ
What does ATAIBECKLEY INC do?
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. The company is headquartered in Amstelveen, Noord-Holland and currently employs 54 full-time employees. The company went IPO on 2021-06-18. The firm focused on developing treatments for mental health disorders. The firm's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.
What is the current price of 9VC stock?
The current stock price of 9VC.DE is 3.426 EUR. The price decreased by -1.21% in the last trading session.
Does ATAIBECKLEY INC pay dividends?
9VC.DE does not pay a dividend.
What is the ChartMill rating of ATAIBECKLEY INC stock?
9VC.DE has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Is ATAIBECKLEY INC (9VC.DE) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 9VC.DE.
Can you provide the market cap for ATAIBECKLEY INC?
ATAIBECKLEY INC (9VC.DE) has a market capitalization of 1.24B EUR. This makes 9VC.DE a Small Cap stock.